skip to content

Cambridge Immunology Network

 

Research

I am a specialist in Nephrology. My main research interests are related to the Pharmacogenomics of monoclonal antibodies in autoimmune diseases-renal immune mediated processes (vasculitis, systemic lupus erithematosus, membranous nephropathy). 

Publications

Key publications: 

Alberici F, Jayne D. Impact of rituximab trials on the treatment of ANCA associated vasculitis. Nephrology Dialysis Transplantation 2013; doi: 10.1093/ndt/gft318

Alberici F, Palmisano A, Urban ML, Maritati F, Oliva E, Manenti L, Ferretti S, Cobelli R, Buzio C, Vaglio A. Methotrexate plus prednisone in patients with relapsing idiopathic retroperitoneal fibrosis.Ann Rheum Dis. 2013 Sep 1;72(9):1584-6.

 

Martorana D, Maritati F, Malerba G, Bonatti F, Alberici F, Oliva E, Sebastio P, Manenti L, Brugnano R, Catanoso MG, Fraticelli P, Guida G, Gregorini G, Possenti S, Moroni G, Leoni A, Pavone L, Pesci A, Sinico RA, Di Toma L, D'Amico M, Tumiati B, D'Ippolito R, Buzio C, Neri TM, Vaglio A. PTPN22 R620W polymorphism in the ANCA-associated vasculitides. Rheumatology (Oxford). 2012 May;51(5):805-12.

Vaglio A, Strehl JD, Manger B, Maritati F, Alberici F, Beyer C, Rech J, Sinico RA, Bonatti F, Battistelli L, Distler JH, Schett G, Zwerina J. IgG4 immune response in Churg-Strauss syndrome. Ann Rheum Dis. 2012 Mar;71(3):390-3.

Vaglio A, Palmisano A, Alberici F, Maggiore U, Ferretti S, Cobelli R, Ferrozzi F, Corradi D, Salvarani C, Buzio C. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: a randomised controlled trial Lancet 2011; 378: 338-46

Dr Federico   Alberici
Not available for consultancy

Affiliations

Classifications: 
Person keywords: 
pharmacogenomics
monoclonal antibodies
Fc gamma receptors